Benjamin T. Dake - Aug 10, 2022 Form 4 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Role
Officer Title: President, Chief Operating Officer and Secretary
Signature
/s/ George A. Eldridge, Attorney-in-Fact
Stock symbol
AVTE
Transactions as of
Aug 10, 2022
Transactions value $
-$314,122
Form type
4
Date filed
8/12/2022, 05:15 PM
Previous filing
Aug 10, 2022
Next filing
Aug 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTE Common Stock Options Exercise $22.1K +12.7K $1.74* 12.7K Aug 10, 2022 Direct F1
transaction AVTE Common Stock Sale -$287K -11.9K -93.87% $24.06 780 Aug 10, 2022 Direct F1, F2
transaction AVTE Common Stock Sale -$19.1K -780 -100% $24.48 0 Aug 10, 2022 Direct F1, F3
transaction AVTE Common Stock Options Exercise $2.34K +1.35K $1.74* 1.35K Aug 11, 2022 Direct F1
transaction AVTE Common Stock Sale -$30.3K -1.27K -94.14% $23.89 79 Aug 11, 2022 Direct F1, F4
transaction AVTE Common Stock Sale -$1.94K -79 -100% $24.55 0 Aug 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -12.7K -38.96% $0.00 19.9K Aug 10, 2022 Common Stock 12.7K $1.74 Direct F1, F5
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -1.35K -6.76% $0.00 18.6K Aug 11, 2022 Common Stock 1.35K $1.74 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 14, 2022.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.43 to $24.40, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.435 to $25.15, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.47 to $24.26, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 A total of 48,293 shares subject to an employee stock option were granted on September 4, 2020, with 10% of the shares vested on January 1, 2020, an additional 22.5% of the shares vested on January 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Officer Title: President, Chief Operating Officer and Secretary